BioCentury
ARTICLE | Financial News

BeiGene amends IPO

January 25, 2016 8:00 AM UTC

BeiGene Ltd., Beijing, China Business: Cancer, Autoimmune Date announced: 2016-01-19 Type: IPO To be raised: Up to $132 million Shares: 5.5 million Price: $22-$24 Underwriters: Goldman Sachs; Morgan S...